NIBEC Co Ltd
138610
Company Profile
Business description
NIBEC Co Ltd is a South Korea based biotechnology company. The company's business portfolio is divided into tissue regeneration biomaterials, peptide drugs and pharmaceutical biomaterials business groups, and oral health products.
Contact
116 Iwol Electric and Electronic Agricultural and Industrial Complex 1
Chungbuk, Iwol-myeon Bamdi-gil
Jincheon-hun
KORT: +82 435327458
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
94
Stocks News & Analysis
stocks
The best way to get rich and retire early
This goes through the different options including shares, property and business ownership and declares a winner, as well as outlining the mindset needed to earn enough to never have to work again.
stocks
Investors overly negative on cheap ASX share
We cut our fair value by 26% but the market has overreacted.
stocks
Overvalued US AI play reports earnings
Strong earnings with high projected growth but price is too rich.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,035.50 | 16.90 | 0.19% |
| CAC 40 | 8,121.07 | 0.00 | 0.00% |
| DAX 40 | 24,283.97 | 4.43 | -0.02% |
| Dow JONES (US) | 48,362.68 | 227.79 | 0.47% |
| FTSE 100 | 9,865.97 | 31.45 | -0.32% |
| HKSE | 25,801.77 | 111.24 | 0.43% |
| NASDAQ | 23,428.83 | 121.21 | 0.52% |
| Nikkei 225 | 50,485.11 | 82.72 | 0.16% |
| NZX 50 Index | 13,509.63 | 1.33 | 0.01% |
| S&P 500 | 6,878.49 | 43.99 | 0.64% |
| S&P/ASX 200 | 8,735.90 | 19.00 | 0.22% |
| SSE Composite Index | 3,917.36 | 26.92 | 0.69% |